Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiotherapy Planning, Computer-Assisted | 18 | 2018 | 65 | 3.240 |
Why?
|
| Phantoms, Imaging | 9 | 2020 | 37 | 1.830 |
Why?
|
| Radiometry | 14 | 2017 | 37 | 1.830 |
Why?
|
| Scattering, Radiation | 8 | 2020 | 36 | 1.640 |
Why?
|
| Brachytherapy | 14 | 2019 | 51 | 1.630 |
Why?
|
| Radiosurgery | 5 | 2020 | 33 | 1.610 |
Why?
|
| Monte Carlo Method | 7 | 2018 | 52 | 1.100 |
Why?
|
| Lung Neoplasms | 3 | 2020 | 509 | 1.010 |
Why?
|
| Algorithms | 7 | 2018 | 347 | 1.000 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2013 | 32 | 0.800 |
Why?
|
| Radiotherapy Dosage | 16 | 2018 | 110 | 0.800 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2018 | 698 | 0.780 |
Why?
|
| Molecular Imaging | 1 | 2020 | 4 | 0.710 |
Why?
|
| Computer Simulation | 7 | 2018 | 183 | 0.650 |
Why?
|
| Electrons | 3 | 2009 | 16 | 0.620 |
Why?
|
| Photons | 1 | 2018 | 3 | 0.600 |
Why?
|
| Radiotherapy, Image-Guided | 1 | 2018 | 6 | 0.600 |
Why?
|
| Models, Biological | 3 | 2004 | 311 | 0.570 |
Why?
|
| Breast Neoplasms | 8 | 2017 | 369 | 0.570 |
Why?
|
| Skin | 2 | 2012 | 99 | 0.480 |
Why?
|
| Magnetics | 2 | 2005 | 3 | 0.470 |
Why?
|
| Radiation Injuries | 2 | 2012 | 28 | 0.410 |
Why?
|
| Thermal Conductivity | 1 | 2012 | 3 | 0.410 |
Why?
|
| Particle Accelerators | 3 | 2009 | 7 | 0.410 |
Why?
|
| Thermography | 1 | 2012 | 14 | 0.410 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2013 | 154 | 0.400 |
Why?
|
| Radiotherapy, Computer-Assisted | 1 | 2011 | 3 | 0.370 |
Why?
|
| Tomography, Spiral Computed | 1 | 2011 | 25 | 0.370 |
Why?
|
| Radiotherapy, Intensity-Modulated | 3 | 2020 | 37 | 0.350 |
Why?
|
| Radiotherapy | 3 | 2009 | 31 | 0.350 |
Why?
|
| Humans | 28 | 2020 | 25692 | 0.340 |
Why?
|
| Computer-Aided Design | 1 | 2009 | 13 | 0.340 |
Why?
|
| Software | 2 | 2011 | 63 | 0.330 |
Why?
|
| Radiotherapy, Conformal | 3 | 2005 | 21 | 0.330 |
Why?
|
| Holography | 1 | 2009 | 1 | 0.330 |
Why?
|
| Imaging, Three-Dimensional | 4 | 2011 | 217 | 0.260 |
Why?
|
| Sensitivity and Specificity | 9 | 2015 | 472 | 0.260 |
Why?
|
| Software Validation | 1 | 2005 | 1 | 0.250 |
Why?
|
| Catheterization | 1 | 2005 | 39 | 0.250 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2005 | 37 | 0.250 |
Why?
|
| Prostatic Neoplasms | 2 | 2018 | 97 | 0.240 |
Why?
|
| Equipment Design | 8 | 2012 | 139 | 0.240 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2005 | 46 | 0.240 |
Why?
|
| Neurosurgical Procedures | 1 | 2005 | 118 | 0.220 |
Why?
|
| Posture | 1 | 2003 | 64 | 0.220 |
Why?
|
| Ethmoid Sinus | 1 | 2003 | 9 | 0.220 |
Why?
|
| Stents | 5 | 2004 | 80 | 0.210 |
Why?
|
| Lung | 1 | 2003 | 159 | 0.200 |
Why?
|
| Intraoperative Care | 2 | 2017 | 43 | 0.200 |
Why?
|
| Reproducibility of Results | 7 | 2012 | 646 | 0.180 |
Why?
|
| Quality Assurance, Health Care | 2 | 2015 | 33 | 0.180 |
Why?
|
| Female | 16 | 2013 | 14273 | 0.170 |
Why?
|
| Electrical Equipment and Supplies | 1 | 2019 | 2 | 0.170 |
Why?
|
| Research Report | 1 | 2019 | 7 | 0.170 |
Why?
|
| Equipment Failure Analysis | 5 | 2012 | 108 | 0.160 |
Why?
|
| Coronary Restenosis | 3 | 2004 | 11 | 0.160 |
Why?
|
| Societies, Medical | 1 | 2019 | 138 | 0.160 |
Why?
|
| Four-Dimensional Computed Tomography | 1 | 2018 | 5 | 0.150 |
Why?
|
| Proton Therapy | 1 | 2018 | 2 | 0.150 |
Why?
|
| Acoustics | 1 | 2018 | 18 | 0.150 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 29 | 0.150 |
Why?
|
| Liver Neoplasms | 1 | 2018 | 93 | 0.140 |
Why?
|
| Angioplasty, Balloon, Coronary | 3 | 2004 | 36 | 0.120 |
Why?
|
| Gamma Rays | 1 | 2015 | 17 | 0.120 |
Why?
|
| Treatment Outcome | 8 | 2013 | 3231 | 0.120 |
Why?
|
| Strontium Radioisotopes | 3 | 2003 | 7 | 0.120 |
Why?
|
| Organs at Risk | 1 | 2013 | 9 | 0.110 |
Why?
|
| Rectum | 1 | 2013 | 43 | 0.110 |
Why?
|
| Urinary Bladder | 1 | 2013 | 22 | 0.110 |
Why?
|
| Decision Support Techniques | 1 | 2013 | 46 | 0.110 |
Why?
|
| Risk Assessment | 4 | 2019 | 618 | 0.110 |
Why?
|
| Graft Occlusion, Vascular | 2 | 2004 | 19 | 0.110 |
Why?
|
| Head and Neck Neoplasms | 1 | 2015 | 146 | 0.110 |
Why?
|
| Radiotherapy, Adjuvant | 3 | 2017 | 49 | 0.110 |
Why?
|
| Artifacts | 2 | 2011 | 31 | 0.100 |
Why?
|
| Mice | 2 | 2012 | 1345 | 0.090 |
Why?
|
| X-Ray Film | 1 | 2011 | 3 | 0.090 |
Why?
|
| Pilot Projects | 1 | 2012 | 392 | 0.090 |
Why?
|
| Calibration | 1 | 2009 | 19 | 0.080 |
Why?
|
| Metals | 1 | 2011 | 136 | 0.080 |
Why?
|
| Radiographic Image Enhancement | 1 | 2009 | 27 | 0.080 |
Why?
|
| Biomarkers | 1 | 2012 | 554 | 0.080 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2009 | 67 | 0.080 |
Why?
|
| Brain Neoplasms | 1 | 2009 | 76 | 0.080 |
Why?
|
| Quality Control | 3 | 2019 | 32 | 0.080 |
Why?
|
| Animals | 2 | 2012 | 3510 | 0.070 |
Why?
|
| Middle Aged | 9 | 2005 | 8403 | 0.070 |
Why?
|
| Radiotherapy, High-Energy | 2 | 2003 | 4 | 0.070 |
Why?
|
| Esthetics | 1 | 2005 | 12 | 0.060 |
Why?
|
| Beta Particles | 2 | 2003 | 6 | 0.060 |
Why?
|
| Iridium Radioisotopes | 1 | 2005 | 4 | 0.060 |
Why?
|
| Bacterial Infections | 1 | 2005 | 41 | 0.060 |
Why?
|
| Radiation Protection | 1 | 2004 | 5 | 0.060 |
Why?
|
| Heart Transplantation | 1 | 2004 | 29 | 0.060 |
Why?
|
| Relative Biological Effectiveness | 1 | 2004 | 5 | 0.060 |
Why?
|
| Body Burden | 1 | 2004 | 5 | 0.060 |
Why?
|
| Coronary Stenosis | 1 | 2004 | 16 | 0.060 |
Why?
|
| Supine Position | 1 | 2003 | 21 | 0.060 |
Why?
|
| Aged | 7 | 2005 | 8501 | 0.060 |
Why?
|
| Models, Statistical | 1 | 2004 | 120 | 0.050 |
Why?
|
| Prone Position | 1 | 2003 | 33 | 0.050 |
Why?
|
| Anisotropy | 1 | 2003 | 42 | 0.050 |
Why?
|
| Reference Values | 1 | 2003 | 183 | 0.050 |
Why?
|
| Combined Modality Therapy | 1 | 2003 | 281 | 0.050 |
Why?
|
| Follow-Up Studies | 5 | 2006 | 1689 | 0.050 |
Why?
|
| Mastectomy, Segmental | 3 | 2005 | 30 | 0.050 |
Why?
|
| Neoplasms | 1 | 2003 | 224 | 0.040 |
Why?
|
| Male | 7 | 2018 | 13917 | 0.040 |
Why?
|
| Workflow | 1 | 2019 | 10 | 0.040 |
Why?
|
| Prospective Studies | 4 | 2005 | 1633 | 0.040 |
Why?
|
| Water | 1 | 2017 | 29 | 0.040 |
Why?
|
| Adult | 3 | 2005 | 7336 | 0.040 |
Why?
|
| Dose-Response Relationship, Radiation | 2 | 2006 | 9 | 0.030 |
Why?
|
| Mice, Hairless | 1 | 2012 | 3 | 0.030 |
Why?
|
| Body Water | 1 | 2012 | 4 | 0.030 |
Why?
|
| Tomography | 1 | 2012 | 13 | 0.030 |
Why?
|
| Blood Vessel Prosthesis Implantation | 2 | 2003 | 21 | 0.030 |
Why?
|
| Radiography | 2 | 2004 | 574 | 0.030 |
Why?
|
| Incidence | 2 | 2005 | 731 | 0.020 |
Why?
|
| Logistic Models | 1 | 2012 | 366 | 0.020 |
Why?
|
| Myocardial Infarction | 2 | 2003 | 129 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2004 | 913 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 2009 | 43 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2005 | 4459 | 0.020 |
Why?
|
| Age Distribution | 1 | 2005 | 84 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2005 | 246 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 2005 | 36 | 0.010 |
Why?
|
| Radiology, Interventional | 1 | 2004 | 6 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2004 | 104 | 0.010 |
Why?
|
| Endpoint Determination | 1 | 2003 | 21 | 0.010 |
Why?
|
| Film Dosimetry | 1 | 2003 | 2 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2003 | 110 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2003 | 67 | 0.010 |
Why?
|
| Myocardial Revascularization | 1 | 2003 | 15 | 0.010 |
Why?
|
| Miniaturization | 1 | 2002 | 2 | 0.010 |
Why?
|
| Death | 1 | 2003 | 35 | 0.010 |
Why?
|
| Survival Rate | 1 | 2004 | 308 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2003 | 154 | 0.010 |
Why?
|
| Illinois | 1 | 2003 | 223 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2003 | 299 | 0.010 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2002 | 7 | 0.010 |
Why?
|
| Angioplasty, Balloon | 1 | 2002 | 13 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2002 | 207 | 0.010 |
Why?
|
| Random Allocation | 1 | 2002 | 116 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2003 | 311 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2003 | 126 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2003 | 443 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2002 | 209 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2005 | 1781 | 0.010 |
Why?
|
| Risk Factors | 1 | 2004 | 2224 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2003 | 3220 | 0.010 |
Why?
|